Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: Part 2

Folia Neuropathologica

Volumn 44, Issue 2, 2006, Pages 102-110

  Collee, J Gerald ^a   Bradley, Ray ^b   Liberski, Paweł P ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Laboratory of Electron Microscopy and Neuropathology Oncology and Medical University ^*  (United Kingdom)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Active surveillance; BSE; TSE Roadmap; vCJD

Indexed keywords

GELATIN; METHIONINE; PRION PROTEIN; VALINE;

APPENDECTOMY; APPENDIX; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CANADA; CAUSE OF DEATH; CODON; CREUTZFELDT JAKOB DISEASE; CROSS INFECTION; DISEASE TRANSMISSION; DRUG USE; FRANCE; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; IMMUNIZATION; INCUBATION TIME; INFECTION RISK; IRELAND; ITALY; JAPAN; MEDICAL RESEARCH; NETHERLANDS; NONHUMAN; OCCUPATION; PORTUGAL; RETICULOENDOTHELIAL SYSTEM; RETROSPECTIVE STUDY; REVIEW; RISK REDUCTION; SAUDI ARABIA; SPAIN; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; SUTURING METHOD; UNITED KINGDOM; UNITED STATES;

EID: 33746119584     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Aguzzi A. Neuro-immune connection in spread of prions in the body? Lancet 1997; 349: 742-743.
2. Baxter HC, Campbell GA, Whittaker AG, Jones AC, Aitken A, Simpson AH, Casey M, Bountiff L, Gibbard L, Baxter RL. Elimination of transmissible spongiform encephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment. J Gen Virol 2005; 86: 2393-2399.
3. Bradley R, Collee JG, Liberski PP Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on - part 1. Folia Neuropathol 2006; 44: 93-101.
4. Bruce ME, McConnell I, Will RG, Ironside JW. Detection of variant Creutzfeldt- Jakob disease. Infectivity in extraneural tissues. Lancet 2001; 358: 208-209.
5. Buschmann A, Groschup MH. Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle. J Infect Dis 2005; 192: 934-942.
6. Casalone C, Zanusso G, Acutis P, Ferrari S, Capucci L, Tagliavini F, Monaco S, Caramelli M. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 2004; 101: 3065-3070.
7. Castilla J, Saá P, Soto C. Detection of prions in blood. Nat Med 2005; 11: 982-985.
8. Collee JG. Transmissible Spongiform Encephalopathies. In: The Microbiological Safety and Quality of Food, Barbara M Lund, TC Baird-Parker, GW Gould eds, vol. II, Aspen, Maryland, USA 2000. Ch 57, p. 1618.
9. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 1999; 354: 317-323.
10. Communicable Disease Report Weekly. New case of transfusion-associated variant-CJD. CDR Weekly 2006; 16: 9 Feb. 2006.
11. Cooper JD, Bird SM. Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts. Int J Epidemiol 2003; 32: 784-791.
12. Dawson M, Hoinville LJ, Hosie BD, Hunter N. Guidance on the use of PrP genotyping as an aid to the control of clinical scrapie. Vet Rec 1998; 142: 623-625.
13. Department of the Environment, Food and Rural Affairs (DEFRA). BSE statistics - confirmed cases of BSE reported worldwide as at 3 Jan. 2006 Website accessed Feb. 2006. http://www.defra.gov.uk/animalh/bse/statistics/bse/worldwide.htm
14. Department of the Environment, Food and Rural Affairs (DEFRA). Transmissible Spongiform Encephalopathies in Great Britain A Progress Report, Dec. 2001. DEFRA, London, 2002, p. 152.
15. Det Norske Veritas. Assessment of the risk of exposure to vCJD infectivity in blood and blood products. Appendix II: Risk assessment of vCJD infectivity in blood. Report forthe department of Health, Revision D. Feb. 2003. DNV Consulting London. Pp 55. Website accessed Feb. 2006. http://www.dnv.co.uk/Binaries/Appll_tcm23-74416.pdf
16. Diringer H, Roehmel J, Beekes M. Effect of repeated oral infection of hamsters with scrapie. J Gen Virol 1998; 79: 609-612.
17. Fichet G, Comoy E, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, Lasmezas CI, Deslys JP. Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004; 364: 521-526.
18. Frosh A, Smith LC, Jackson CJ, Linehan JM, Brandner S, Wadsworth JD, Collinge J. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related protein. Lancet 2004; 364: 1260-1262.
19. Gavier-Widén D, Stack MJ, Baron T Diagnosis of transmissible spongiform encephalopathies in animals: a review. J Vet Diagn Invest 2005; 17: 509-527.
20. Goldmann W, Baylis M, Chihota C, Stevenson E, Hunter N. Frequencies of PrP gene haplotypes in British sheep flocks and the implications for breeding programmes. J Appl Microbiol 2005; 98: 1294-1302.
21. Gravenor MB, Stallard N, Curnow R, McLean AR. Repeated challenge with prion disease: the risk of infection and impact on incubation period. Proc Natl Acad Sci U S A 2003; 100: 10960-10965.
22. Gregod L, McCombie N, Palmer D, Birch P, Sowemimo-Coker SO, Giulivi A, Rohwer RG. Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 2004; 364: 529-531.
23. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998; 352: 703-704.
24. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Penney M, Ritchie D, Ironside JW. Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 2002; 325: 633-634.
25. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, Penney M, Hegazy D, Ironside JW. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203: 733-739.
26. Hilton DA, Sutak J, Smith MEF, Penney M, Conyers L, Edwards P, McCardle L, Ritchie D, Head MW, Wiley CA, Ironside JW. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 2004; 57: 300-302.
27. Ironside JW, Hilton DA, Ghani A, Johnston N, Conyers L, McCardle LM, Best D. Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet 2000; 255: 1693-1694.
28. Jacquemot C, Cuche C, Dormont D, Lazarini F. High incidence of scrapie induced by repeated injections of subinfectious prion doses. J Virol 2005; 79: 8904-8908.
29. Joiner S, Linehan J, Brandner S, Wadsworth JDF, Collinge J. Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2002; 73: 597-603.
30. Sc in mammary glands of sheep affected by scrapie and mastitis. Nat Med 2005; 11: 1137-1138.
31. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Wilt RG. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417-421.
32. National CJD Surveillance Unit. Thirteenth Annual Report for 2004, 2005. Website accessed Feb. 2006. http://www.cjd.ed.ac.uk/report13.pdf
33. National Creutzfeldt-Jakob Disease Surveillance Unit. Website accessed Feb.2006. http://www.cjd.ed.ac.uk/figures.htm
34. Office International des Epizooties (OIE). Website accessed Feb. 2006. http://www.oie.int/eng/info/en_esbru.htm
35. Office International des Epizooties (OIE). Website accessed Feb. 2006. http://www.oie.int/eng/info/en_esbmonde.htm
36. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364: 527-529.
37. Prusiner SB. Novel proteinaceous particles cause scrapie. Science 1982; 216:136-144.
38. Shmakov AN, Ghosh S. Prion proteins and the gut: une liaison dangereuse? Gut 2001; 48: 443-447.
39. Spongiform Encephalopathy Advisory Committee (SEAC). Draft minutes of 90th meeting held on 24 November 2005. Website accessed Feb. 2006. http://www.seac.gov.uk/minutes/final90.pdf
40. Taylor DM. Resistance of TSE agents to decontamination. In: Rabenau HF, Cinatl J, Doerr HW, eds. Prions. A challenge for science, medicine and the public health system. Contrib Microb. Basel Karger 2004; 11: 136-145.
41. Valleron AJ, Boelle PY, Will RG, Cesbron JY. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 2001; 294: 1726-1728.